Sep 30, 2024

Semler Scientific Q3 2024 Earnings Report

Semler Scientific reported a decrease in revenue but an increase in net income for Q3 2024, while also purchasing additional Bitcoin.

Key Takeaways

Semler Scientific reported a decrease in revenue of 17% to $13.5 million, but net income increased by 2% to $5.6 million. The company's income from operations decreased by 20% to $5.1 million. The company purchased additional bitcoins, bringing its total holdings to 1,058.

Revenue decreased by 17% to $13.5 million.

Net income increased by 2% to $5.6 million.

Income from operations decreased by 20% to $5.1 million.

Purchased additional 47 bitcoins for $3.0 million.

Total Revenue
$13.5M
Previous year: $16.3M
-17.2%
EPS
$0.72
Previous year: $0.71
+1.4%
Cash and Equivalents
$6.57M
Previous year: $37.5M
-82.5%
Total Assets
$92.2M
Previous year: $79.4M
+16.1%

Semler Scientific

Semler Scientific

Forward Guidance

Semler Scientific is focused on acquiring and holding bitcoin, while supporting innovation and growth in its healthcare business. They plan to continue purchasing bitcoin with cash from operations and exploring additional financing opportunities.

Positive Outlook

  • Focused on acquiring and holding bitcoin.
  • Supporting innovation in healthcare business.
  • Exploring additional financing opportunities.
  • Plan to continue to purchase bitcoin with cash from operations.
  • Plan to purchase bitcoin with cash proceeds from ATM program.

Challenges Ahead

  • Risks inherent with investing in bitcoin, including bitcoin's volatility
  • Risk of implementing a new bitcoin treasury strategy
  • Risk that insurance plans and other customers will not continue to license its cardiovascular testing products
  • Risk of changes in the reimbursement landscape for its customers including related to the Centers for Medicare and Medicaid Services (CMS) rate announcement
  • Risk of obtaining a new 510(k) clearance for expanded indications